| 000 | 01845 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517115940.0 | ||
| 264 | 0 | _c20170515 | |
| 008 | 201705s 0 0 eng d | ||
| 022 | _a1098-5514 | ||
| 024 | 7 |
_a10.1128/JVI.01491-16 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChandrasekharan, Jayashree A | |
| 245 | 0 | 0 |
_aAltering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis. _h[electronic resource] |
| 260 |
_bJournal of virology _cDec 2016 |
||
| 300 |
_a11020-11031 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdaptor Proteins, Signal Transducing _xdeficiency |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
| 650 | 0 | 4 |
_aArachidonate 5-Lipoxygenase _xgenetics |
| 650 | 0 | 4 | _aCRISPR-Cas Systems |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCyclooxygenase 2 _xgenetics |
| 650 | 0 | 4 |
_aEndothelial Cells _xdrug effects |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 |
_aHerpesvirus 8, Human _xgenetics |
| 650 | 0 | 4 | _aHost-Pathogen Interactions |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInflammation |
| 650 | 0 | 4 |
_aLipoxins _xpharmacology |
| 650 | 0 | 4 |
_aLymphoma, Primary Effusion _xgenetics |
| 650 | 0 | 4 |
_aMicroRNAs _xgenetics |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase 1 _xgenetics |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase 3 _xgenetics |
| 650 | 0 | 4 |
_aNF-kappa B _xgenetics |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xgenetics |
| 650 | 0 | 4 |
_aRNA, Viral _xgenetics |
| 650 | 0 | 4 |
_aSarcoma, Kaposi _xgenetics |
| 650 | 0 | 4 | _aSignal Transduction |
| 700 | 1 | _aHuang, Xiao M | |
| 700 | 1 | _aHwang, Alexander C | |
| 700 | 1 | _aSharma-Walia, Neelam | |
| 773 | 0 |
_tJournal of virology _gvol. 90 _gno. 24 _gp. 11020-11031 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/JVI.01491-16 _zAvailable from publisher's website |
| 999 |
_c26464213 _d26464213 |
||